The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
出版年份 2016 全文链接
标题
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
作者
关键词
Alzheimer’s disease, Biomarker, Cerebrospinal fluid, Synaptotagmin, Mass spectrometry, Immunopurification, Selected reaction monitoring, Parallel reaction monitoring
出版物
Alzheimers Research & Therapy
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-10-03
DOI
10.1186/s13195-016-0208-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling
- (2015) Kate Baker et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline
- (2015) Sarah Gourmaud et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Synaptotagmin-1 and -7 Are Redundantly Essential for Maintaining the Capacity of the Readily-Releasable Pool of Synaptic Vesicles
- (2015) Taulant Bacaj et al. PLOS BIOLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study
- (2013) François Mouton-Liger et al. JOURNAL OF NEUROLOGY
- Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease
- (2012) François Mouton-Liger et al. BIOLOGICAL PSYCHIATRY
- Molecular machines governing exocytosis of synaptic vesicles
- (2012) Reinhard Jahn et al. NATURE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started